Show simple item record

dc.contributor.authorBhatt, N Ben_GB
dc.contributor.authorBaudin, Een_GB
dc.contributor.authorMeggi, Ben_GB
dc.contributor.authorda Silva, Cen_GB
dc.contributor.authorBarrail-Tran, Aen_GB
dc.contributor.authorFurlan, Ven_GB
dc.contributor.authorGrinsztejn, Ben_GB
dc.contributor.authorBonnet, Men_GB
dc.contributor.authorTaburet, A-Men_GB
dc.date.accessioned2014-12-11T22:40:13Z
dc.date.available2014-12-11T22:40:13Z
dc.date.issued2014-09-18
dc.identifier.citationNevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship. 2014: J. Antimicrob. Chemother.en_GB
dc.identifier.issn1460-2091
dc.identifier.pmid25239466
dc.identifier.doi10.1093/jac/dku348
dc.identifier.urihttp://hdl.handle.net/10144/337110
dc.description.abstractWe describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.
dc.languageENG
dc.language.isoenen
dc.publisherOxford University Pressen_GB
dc.rightsArchived with thanks to The Journal of Antimicrobial Chemotherapy and Oxford University Pressen_GB
dc.titleNevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationshipen
dc.identifier.journalJournal of Antimicrobial Chemotherapyen_GB
refterms.dateFOA2019-03-04T11:39:33Z
html.description.abstractWe describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.


Files in this item

Thumbnail
Name:
Bhatt N et al - 2014 - Nevirapine ...
Size:
250.7Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record